189 related articles for article (PubMed ID: 7824089)
21. Long-term expression of full-length human dystrophin in transgenic mdx mice expressing internally deleted human dystrophins.
Ferrer A; Foster H; Wells KE; Dickson G; Wells DJ
Gene Ther; 2004 Jun; 11(11):884-93. PubMed ID: 14985788
[TBL] [Abstract][Full Text] [Related]
22. Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle.
Dunant P; Walter MC; Karpati G; Lochmüller H
Muscle Nerve; 2003 May; 27(5):624-7. PubMed ID: 12707984
[TBL] [Abstract][Full Text] [Related]
23. Cell transplantation and gene therapy in muscular dystrophy.
Morgan JE; Partridge TA
Bioessays; 1992 Sep; 14(9):641-5. PubMed ID: 1365921
[TBL] [Abstract][Full Text] [Related]
24. Effect of propylthiouracil-induced hypothyroidism on the onset of skeletal muscle necrosis in dystrophin-deficient mdx mice.
McArdle A; Helliwell TR; Beckett GJ; Catapano M; Davis A; Jackson MJ
Clin Sci (Lond); 1998 Jul; 95(1):83-9. PubMed ID: 9662489
[TBL] [Abstract][Full Text] [Related]
25. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
26. Localization and characterization of dystrophin in muscle biopsy specimens from Duchenne muscular dystrophy and various neuromuscular disorders.
Uchino M; Araki S; Miike T; Teramoto H; Nakamura T; Yasutake T
Muscle Nerve; 1989 Dec; 12(12):1009-16. PubMed ID: 2695839
[TBL] [Abstract][Full Text] [Related]
27. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
[TBL] [Abstract][Full Text] [Related]
28. Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.
Fassati A; Wells DJ; Sgro Serpente PA; Walsh FS; Brown SC; Strong PN; Dickson G
J Clin Invest; 1997 Aug; 100(3):620-8. PubMed ID: 9239410
[TBL] [Abstract][Full Text] [Related]
29. Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
Lu QL; Mann CJ; Lou F; Bou-Gharios G; Morris GE; Xue SA; Fletcher S; Partridge TA; Wilton SD
Nat Med; 2003 Aug; 9(8):1009-14. PubMed ID: 12847521
[TBL] [Abstract][Full Text] [Related]
30. Normal cochlear function in mdx and mdx(Cv3) Duchenne muscular dystrophy mouse models.
Pillers DA; Duncan NM; Dwinnell SJ; Rash SM; Kempton JB; Trune DR
Laryngoscope; 1999 Aug; 109(8):1310-2. PubMed ID: 10443839
[TBL] [Abstract][Full Text] [Related]
31. Dystroglycan expression in the wild type and mdx mouse neural retina: synaptic colocalization with dystrophin, dystrophin-related protein but not laminin.
Montanaro F; Carbonetto S; Campbell KP; Lindenbaum M
J Neurosci Res; 1995 Nov; 42(4):528-38. PubMed ID: 8568939
[TBL] [Abstract][Full Text] [Related]
32. [Expression of the human dystrophin gene in mdx mouse skeletal muscles after ballistic transfection].
Zelenin AV; Tarasenko OV; Kolesnikov VA; Mikhaĭlov VM; Kiselev AV; Baranov AN; Zelenina IA; Shafei RA; Ivashchenko TE; Evgrafov OV
Genetika; 1998 Jun; 34(6):730-6. PubMed ID: 9719921
[TBL] [Abstract][Full Text] [Related]
33. A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system.
Kudoh H; Ikeda H; Kakitani M; Ueda A; Hayasaka M; Tomizuka K; Hanaoka K
Biochem Biophys Res Commun; 2005 Mar; 328(2):507-16. PubMed ID: 15694376
[TBL] [Abstract][Full Text] [Related]
34. Intraperitoneal administration of phosphorothioate antisense oligodeoxynucleotide against splicing enhancer sequence induced exon skipping in dystrophin mRNA expressed in mdx skeletal muscle.
Takeshima Y; Yagi M; Wada H; Matsuo M
Brain Dev; 2005 Oct; 27(7):488-93. PubMed ID: 16198206
[TBL] [Abstract][Full Text] [Related]
35. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle.
Akkaraju GR; Huard J; Hoffman EP; Goins WF; Pruchnic R; Watkins SC; Cohen JB; Glorioso JC
J Gene Med; 1999; 1(4):280-9. PubMed ID: 10738561
[TBL] [Abstract][Full Text] [Related]
36. Microdystrophin delivery in dystrophin-deficient (mdx) mice by genetically-corrected syngeneic MSCs transplantation.
Xiong F; Xu Y; Zheng H; Lu X; Feng S; Shang Y; Li Y; Zhang Y; Jin S; Zhang C
Transplant Proc; 2010 Sep; 42(7):2731-9. PubMed ID: 20832578
[TBL] [Abstract][Full Text] [Related]
37. The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy.
Danko I; Chapman V; Wolff JA
Pediatr Res; 1992 Jul; 32(1):128-31. PubMed ID: 1635838
[TBL] [Abstract][Full Text] [Related]
38. Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma.
Chamberlain JS; Metzger J; Reyes M; Townsend D; Faulkner JA
FASEB J; 2007 Jul; 21(9):2195-204. PubMed ID: 17360850
[TBL] [Abstract][Full Text] [Related]
39. Common pathological mechanisms in mouse models for muscular dystrophies.
Turk R; Sterrenburg E; van der Wees CG; de Meijer EJ; de Menezes RX; Groh S; Campbell KP; Noguchi S; van Ommen GJ; den Dunnen JT; 't Hoen PA
FASEB J; 2006 Jan; 20(1):127-9. PubMed ID: 16306063
[TBL] [Abstract][Full Text] [Related]
40. Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin.
Vilquin JT; Wagner E; Kinoshita I; Roy R; Tremblay JP
J Cell Biol; 1995 Nov; 131(4):975-88. PubMed ID: 7490298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
